NEUROPACE INC (NPCE) — insider trading
Health Care · NASDAQ
NEUROPACE INC (NPCE) has 30 reported SEC Form 4 insider transactions in our data (latest 2026-09-24).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Morrell Martha | Officer (CHIEF MEDICAL OFFICER) | Shares withheld for taxes / exercise cost | 335 | $13.97 | $4.7K | Form 4 |
| 2026-09-20 | Williams Patrick F. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 1,162 | $14.28 | $16.6K | Form 4 |
| 2026-09-03 | Becker Joel | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 1,310 | $14.75 | $19.3K | Form 4 |
| 2026-08-27 | Becker Joel | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 1,126 | $14.13 | $15.9K | Form 4 |
| 2026-08-27 | Morrell Martha | Officer (CHIEF MEDICAL OFFICER) | Shares withheld for taxes / exercise cost | 358 | $14.13 | $5.1K | Form 4 |
| 2026-06-24 | Morrell Martha | Officer (CHIEF MEDICAL OFFICER) | Shares withheld for taxes / exercise cost | 335 | $16.22 | $5.4K | Form 4 |
| 2026-06-19 | Kumar Rakhi | Director | Grant / award / vesting | 989 | $15.63 | $15.5K | Form 4 |
| 2026-06-19 | Fischer Frank M | Director | Grant / award / vesting | 1,467 | $15.63 | $22.9K | Form 4 |
| 2026-06-19 | Geiger Uri | Director | Grant / award / vesting | 789 | $15.63 | $12.3K | Form 4 |
| 2026-06-05 | Andrade Lisa | Director | Grant / award / vesting (derivative) | 5,368 | — | $0 | Form 4 |
| 2026-06-05 | Andrade Lisa | Director | Grant / award / vesting | 2,890 | — | $0 | Form 4 |
| 2026-06-05 | Ryan Renee | Director | Grant / award / vesting (derivative) | 5,368 | — | $0 | Form 4 |
| 2026-06-05 | Ryan Renee | Director | Grant / award / vesting | 2,890 | — | $0 | Form 4 |
| 2026-06-05 | Kumar Rakhi | Director | Grant / award / vesting (derivative) | 5,368 | — | $0 | Form 4 |
| 2026-06-05 | Kumar Rakhi | Director | Grant / award / vesting | 2,890 | — | $0 | Form 4 |
| 2026-06-05 | Geiger Uri | Director | Grant / award / vesting (derivative) | 5,368 | — | $0 | Form 4 |
| 2026-06-05 | Geiger Uri | Director | Grant / award / vesting | 2,890 | — | $0 | Form 4 |
| 2026-06-05 | Fischer Frank M | Director | Grant / award / vesting (derivative) | 5,368 | — | $0 | Form 4 |
| 2026-06-05 | Fischer Frank M | Director | Grant / award / vesting | 2,890 | — | $0 | Form 4 |
| 2026-06-05 | Huennekens R Scott | Director | Grant / award / vesting (derivative) | 5,368 | — | $0 | Form 4 |
| 2026-06-05 | Huennekens R Scott | Director | Grant / award / vesting | 2,890 | — | $0 | Form 4 |
| 2026-06-03 | Becker Joel | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 1,255 | $15.88 | $19.9K | Form 4 |
| 2026-05-27 | Morrell Martha | Officer (CHIEF MEDICAL OFFICER) | Shares withheld for taxes / exercise cost | 358 | $17.06 | $6.1K | Form 4 |
| 2026-05-27 | Becker Joel | Director, Officer (CHIEF EXECUTIVE OFFICER) | Shares withheld for taxes / exercise cost | 1,126 | $17.06 | $19.2K | Form 4 |
| 2026-05-15 | Becker Joel | Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant / award / vesting (derivative) | 122,190 | — | $0 | Form 4 |
| 2026-05-15 | Becker Joel | Director, Officer (CHIEF EXECUTIVE OFFICER) | Grant / award / vesting | 45,880 | — | $0 | Form 4 |
| 2026-05-15 | Morrell Martha | Officer (CHIEF MEDICAL OFFICER) | Grant / award / vesting (derivative) | 14,550 | — | $0 | Form 4 |
| 2026-05-15 | Morrell Martha | Officer (CHIEF MEDICAL OFFICER) | Grant / award / vesting | 5,460 | — | $0 | Form 4 |
| 2026-05-15 | Williams Patrick F. | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 44,800 | — | $0 | Form 4 |
| 2026-05-15 | Williams Patrick F. | Officer (Chief Financial Officer) | Grant / award / vesting | 16,820 | — | $0 | Form 4 |
Ask the chat about NPCE's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: NEUROPACE INC (NPCE).
Last updated 2026-09-24 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.